Moderna, Inc. · NASDAQ:MRNA
Bancel Stephane sold 499,246 Moderna, Inc. shares (Form 4)
Traded Aug 5 to Aug 6, 2026 · Filed Aug 7, 2026
From Aug 5 to Aug 6, 2026, Bancel Stephane (Director, Chief Executive Officer) sold 499,246 Moderna, Inc. shares at an average US$57.52 for US$28.7M under a trading plan, leaving 6,440,260 shares. Filed Aug 7, 2026 (Form 4).
- Sold
- 499,246 shares
- Price
- US$57.52 average (US$56.21 to US$58.79)
- Value
- US$28.7M
- Holding after
- 6,440,260 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 5, 2026 | Common Stock | Option exercise | 499,246 | US$19.15 | 6,687,037 | Direct |
| Aug 5, 2026 | Common Stock | Sale | 147,473 | US$56.21 | 6,539,564 | Direct |
| Aug 5, 2026 | Common Stock | Sale | 124,838 | US$56.96 | 6,414,726 | Direct |
| Aug 5, 2026 | Common Stock | Sale | 39,891 | US$58.12 | 6,374,835 | Direct |
| Aug 5, 2026 | Common Stock | Sale | 187,044 | US$58.79 | 6,187,791 | Direct |
| Aug 6, 2026 | Common Stock | Option exercise | 252,469 | US$19.15 | 6,440,260 | Direct |